Journal article
EEG Biomarkers to Predict Response to Sertraline and Placebo Treatment in Major Depressive Disorder
Abstract
OBJECTIVE: Major depressive disorder (MDD) is a persistent psychiatric condition, and the leading cause of disability, affecting up to 5% of the population worldwide. Antidepressant medications (ADMs) are often the first-line treatment for MDD, but it may take the clinician months of "trial and error" to find an effective ADM for a particular patient. Therefore, identification of predictive biomarkers that can be used to accurately determine …
Authors
Oakley T; Coskuner J; Cadwallader A; Ravan M; Hasey G
Journal
IEEE Transactions on Biomedical Engineering, Vol. 70, No. 3, pp. 909–919
Publisher
Institute of Electrical and Electronics Engineers (IEEE)
Publication Date
March 2023
DOI
10.1109/tbme.2022.3204861
ISSN
0018-9294